Dr. Shoa Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties.

Dr. David M. Maahs is the Lucile Salter Packard Professor of Pediatrics, Division Chief of Pediatric Endocrinology, and Associate Chair for Academic Affairs in Pediatrics at Stanford University and the Lucile Packard Children’s Hospital. He earned his MD followed by Pediatric Residency at the University of New Mexico. After 3 years on New Mexico’s faculty, Dr. Maahs completed a Pediatric Endocrinology fellowship and a concurrent PhD in Epidemiology at the University of Colorado.

Dr. Yong Yean Kim's lab is interested in translational science to bring new therapies to clinical trials. In particular, they are interested in pediatric sarcomas which have not had advancement in clinical treatment for decades. Current projects in the lab focus on understanding of the biology of fusion transcription factor PAX3::FOXO1 which is the driver mutation in fusion positive rhabdomyosarcoma. PAX3::FOXO1 is a powerful oncogenic transcription factor which rewires the transcriptional organization to lock the cancer cell in the proliferative state.

Dr. Bruno Soares is an Associate Professor of Radiology at Stanford University School of Medicine and serves as the Section Chief of Pediatric Neuroradiology at Lucile Packard Children’s Hospital at Stanford since June 2023. 

Dr. Alma-Martina Cepika is an immunologist with an extensive background in human immunology, genomics, and translational research. Her goal is to understand the mechanisms governing immune tolerance, and leverage this knowledge towards developing new therapies. 

Dr. Sheng Xu is a tenured professor and the inaugural Director of Emerging Technologies in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University, with a courtesy appointment in Electrical Engineering. He earned his B.S. degree in Chemistry from Peking University and his Ph.D. in Materials Science and Engineering from the Georgia Institute of Technology. Subsequently, he pursued postdoctoral studies at the Materials Research Laboratory at the University of Illinois at Urbana-Champaign.

Dr. David Cox is an Assistant Professor of Genetics and by courtesy of Medicine (Hematology) at Stanford University and Principal Investigator of the Cox Lab (coxlab.bio). He is also a ChEM-H Institute Scholar and Chan Zuckerberg Biohub Investigator.

Dr. Yaochun Yu's research focuses on functional environmental microbiology and environmental analytical chemistry to uncover and harness microorganisms for chemical biotransformation. Dr. Yu's lab integrates high-resolution mass spectrometry, meta-omics sequencing, molecular microbiology and biochemistry, and computational modeling to identify the functional microbes, genes, and enzymes that drive these processes. Building on these mechanistic insights, they aim to develop environmentally benign chemicals and novel biosolutions for bioremediation and waste-to-resource recovery.

Dr. Stefano Ermon is an Assistant Professor in the Department of Computer Science at Stanford University.

Dr. Robert Hawkins is interested in the cognitive mechanisms that allow people to flexibly communicate, collaborate, and coordinate with one another in social interactions. He received his PhD in Psychology from Stanford University in 2019 and was a C.V. Starr Fellow at the Princeton Neuroscience Institute prior to starting as an Assistant Professor of Linguistics at Stanford in 2024.